The Province - - ADVERTISMENT -

When some­one over­doses, time is

crit­i­cal to sav­ing their life. Get­ting a treat­ment such as nalox­one — which can re­verse the ef­fects of an over­dose and re­sus­ci­tate them — into an in­di­vid­ual as quickly as pos­si­ble is cru­cial. But how that ther­apy is pack­aged can play an im­por­tant part in time­li­ness.

Cur­rently, there are two forms of stor­ing the drug for use — in an am­poule or a vial. The lat­ter is much more user-friendly, and has less risk for the per­son de­liv­er­ing the drug and the per­son re­ceiv­ing it.Am­poules, by con­trast are one-piece glass con­tain­ers that need to be bro­ken be­fore use.

“When you open an am­poule, there is a risk of cutting your­self with the bro­ken am­poule, or even hav­ing glass shards fall into the drug,” says Omega Lab­o­ra­to­ries, the only Cana­dian com­pany cur­rently pro­duc­ing nalox­one 0.4mg/1mL in vials. “Pa­tient safety is our ut­most con­cern. That’s why it’s im­por­tant to make a prod­uct that is safer for peo­ple.” Given the ease of ad­min­is­ter­ing the drug, more phar­ma­cies should stock the vial for­mat.

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.